Holly moved from bedside standard of care practice to the clinical trial arena as a research R.N. so she could be actively engaged in bringing new and better ways of preventing and alleviating disease, pain and suffering to patients. Over the past 24+ years, Holly has worn many hats within clinical research with the patient always at the center.
Holly has served many roles in clinical research, including site trial conduct, inside pharma and biopharma companies both large and small and in in vitro/companion diagnostics (IVD) and local IRB. She also worked for an oncology-immunotherapy focused not-for-profit. Her areas of involvement have included clinical science, quality assurance (auditor) and IRB with a career emphasis in clinical operations.